13D Filing: Great Point Partners and Bovie Medical Corp (BVX)

Class D Series of GEF-PS, LP
(“GEF-PS”) used its own funds to purchase 336,206 shares of Common Stock (the “GEF-PS Shares”) and Series
A 6% preferred stock convertible into 489,669 shares of Common Stock (the “GEF-PS Preferred Shares”).

WS Investments II, LLC (“WS”)
used its own funds to purchase 39,260 shares of Common Stock (“WS Shares”) and Series A 6% preferred stock convertible
into 70,514 shares of Common Stock (the “WS Preferred Shares”).

The provisions of the preferred
stock described above restrict the conversion of such preferred stock to the extent that, after giving effect to such conversion,
the holder of the preferred stock and its affiliates and any other person or entities with which such holder would constitute a
group would beneficially own in excess of 9.985% of the number of shares of Common Stock of the Issuer outstanding immediately
after giving effect to such exercise (the “Ownership Cap”). Therefore, the reporting persons could be deemed to beneficially
own such number of shares underlying such preferred stock as would result in total beneficial ownership by such reporting persons
up to the Ownership Cap.

See Item 5 below for information
with respect to Great Point, Dr. Jay and Mr. Kroin.

Item 4.

Purpose of Transaction

The securities of
the Issuer were acquired for investment. Each of the Reporting Persons has, subsequent to the date of acquisition of the
securities, determined to seek to influence the board of directors of the Issuer to take more affirmative steps designed to
maximize shareholder value, including, if appropriate, seeking changes to the composition of the board of directors, and/or
encouraging the Issuer to evaluate strategic alternatives. None of the Reporting Persons has yet formulated any specific plan
to implement such new determination. See Item 6 below for additional information.

Item 5.

Interest in Securities of the Issuer

BMVF beneficially owns in the
aggregate 1,270,255 BMVF Shares and 18,551 BMVF Preferred Shares. Such shares in the aggregate constitute 4.73% of the shares of
Common Stock outstanding, computed in accordance with Rule 13d-3. BMVF shares voting and dispositive power over the BMVF Shares
and BMVF Preferred Shares.

BOVF beneficially owns in the
aggregate 710,610 BOVF Shares and 10,378 BOVF Preferred Shares. Such shares in the aggregate constitute 2.65% of the shares of
Common Stock outstanding, computed in accordance with Rule 13d-3. BOVF shares voting and dispositive power over the BOVF Shares
and BOVF Preferred Shares.

BIVF beneficially owns in the
aggregate 326,660 BIVF Shares and 4,771 BIVF Preferred Shares. Such shares in the aggregate constitute 1.22% of the shares of Common
Stock outstanding, computed in accordance with Rule 13d-3. BIVF shares voting and dispositive power of the BIVF Shares and BIVF
Preferred Shares.